Cargando…

Antibacterial and Sterilizing Effect of Benzylpenicillin in Tuberculosis

The modern chemotherapy era started with Fleming's discovery of benzylpenicillin. He demonstrated that benzylpenicillin did not kill Mycobacterium tuberculosis. In this study, we found that >64 mg/liter of static benzylpenicillin concentrations killed 1.16 to 1.43 log(10) CFU/ml below starti...

Descripción completa

Detalles Bibliográficos
Autores principales: Deshpande, Devyani, Srivastava, Shashikant, Bendet, Paula, Martin, Katherine R., Cirrincione, Kayle N., Lee, Pooi S., Pasipanodya, Jotam G., Dheda, Keertan, Gumbo, Tawanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786797/
https://www.ncbi.nlm.nih.gov/pubmed/29180526
http://dx.doi.org/10.1128/AAC.02232-17
_version_ 1783295828888125440
author Deshpande, Devyani
Srivastava, Shashikant
Bendet, Paula
Martin, Katherine R.
Cirrincione, Kayle N.
Lee, Pooi S.
Pasipanodya, Jotam G.
Dheda, Keertan
Gumbo, Tawanda
author_facet Deshpande, Devyani
Srivastava, Shashikant
Bendet, Paula
Martin, Katherine R.
Cirrincione, Kayle N.
Lee, Pooi S.
Pasipanodya, Jotam G.
Dheda, Keertan
Gumbo, Tawanda
author_sort Deshpande, Devyani
collection PubMed
description The modern chemotherapy era started with Fleming's discovery of benzylpenicillin. He demonstrated that benzylpenicillin did not kill Mycobacterium tuberculosis. In this study, we found that >64 mg/liter of static benzylpenicillin concentrations killed 1.16 to 1.43 log(10) CFU/ml below starting inoculum of extracellular and intracellular M. tuberculosis over 7 days. When we added the β-lactamase inhibitor avibactam, benzylpenicillin maximal kill (E(max)) of extracellular log-phase-growth M. tuberculosis was 6.80 ± 0.45 log(10) CFU/ml at a 50% effective concentration (EC(50)) of 15.11 ± 2.31 mg/liter, while for intracellular M. tuberculosis it was 2.42 ± 0.14 log(10) CFU/ml at an EC(50) of 6.70 ± 0.56 mg/liter. The median penicillin (plus avibactam) MIC against South African clinical M. tuberculosis strains (80% either multidrug or extensively drug resistant) was 2 mg/liter. We mimicked human-like benzylpenicillin and avibactam concentration-time profiles in the hollow-fiber model of tuberculosis (HFS-TB). The percent time above the MIC was linked to effect, with an optimal exposure of ≥65%. At optimal exposure in the HFS-TB, the bactericidal activity in log-phase-growth M. tuberculosis was 1.44 log(10) CFU/ml/day, while 3.28 log(10) CFU/ml of intracellular M. tuberculosis was killed over 3 weeks. In an 8-week HFS-TB study of nonreplicating persistent M. tuberculosis, penicillin-avibactam alone and the drug combination of isoniazid, rifampin, and pyrazinamide both killed >7.0 log(10) CFU/ml. Monte Carlo simulations of 10,000 preterm infants with disseminated disease identified an optimal dose of 10,000 U/kg (of body weight)/h, while for pregnant women or nonpregnant adults with pulmonary tuberculosis the optimal dose was 25,000 U/kg/h, by continuous intravenous infusion. Penicillin-avibactam should be examined for effect in pregnant women and infants with drug-resistant tuberculosis, to replace injectable ototoxic and teratogenic second-line drugs.
format Online
Article
Text
id pubmed-5786797
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-57867972018-02-07 Antibacterial and Sterilizing Effect of Benzylpenicillin in Tuberculosis Deshpande, Devyani Srivastava, Shashikant Bendet, Paula Martin, Katherine R. Cirrincione, Kayle N. Lee, Pooi S. Pasipanodya, Jotam G. Dheda, Keertan Gumbo, Tawanda Antimicrob Agents Chemother Experimental Therapeutics The modern chemotherapy era started with Fleming's discovery of benzylpenicillin. He demonstrated that benzylpenicillin did not kill Mycobacterium tuberculosis. In this study, we found that >64 mg/liter of static benzylpenicillin concentrations killed 1.16 to 1.43 log(10) CFU/ml below starting inoculum of extracellular and intracellular M. tuberculosis over 7 days. When we added the β-lactamase inhibitor avibactam, benzylpenicillin maximal kill (E(max)) of extracellular log-phase-growth M. tuberculosis was 6.80 ± 0.45 log(10) CFU/ml at a 50% effective concentration (EC(50)) of 15.11 ± 2.31 mg/liter, while for intracellular M. tuberculosis it was 2.42 ± 0.14 log(10) CFU/ml at an EC(50) of 6.70 ± 0.56 mg/liter. The median penicillin (plus avibactam) MIC against South African clinical M. tuberculosis strains (80% either multidrug or extensively drug resistant) was 2 mg/liter. We mimicked human-like benzylpenicillin and avibactam concentration-time profiles in the hollow-fiber model of tuberculosis (HFS-TB). The percent time above the MIC was linked to effect, with an optimal exposure of ≥65%. At optimal exposure in the HFS-TB, the bactericidal activity in log-phase-growth M. tuberculosis was 1.44 log(10) CFU/ml/day, while 3.28 log(10) CFU/ml of intracellular M. tuberculosis was killed over 3 weeks. In an 8-week HFS-TB study of nonreplicating persistent M. tuberculosis, penicillin-avibactam alone and the drug combination of isoniazid, rifampin, and pyrazinamide both killed >7.0 log(10) CFU/ml. Monte Carlo simulations of 10,000 preterm infants with disseminated disease identified an optimal dose of 10,000 U/kg (of body weight)/h, while for pregnant women or nonpregnant adults with pulmonary tuberculosis the optimal dose was 25,000 U/kg/h, by continuous intravenous infusion. Penicillin-avibactam should be examined for effect in pregnant women and infants with drug-resistant tuberculosis, to replace injectable ototoxic and teratogenic second-line drugs. American Society for Microbiology 2018-01-25 /pmc/articles/PMC5786797/ /pubmed/29180526 http://dx.doi.org/10.1128/AAC.02232-17 Text en Copyright © 2018 Deshpande et al. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Experimental Therapeutics
Deshpande, Devyani
Srivastava, Shashikant
Bendet, Paula
Martin, Katherine R.
Cirrincione, Kayle N.
Lee, Pooi S.
Pasipanodya, Jotam G.
Dheda, Keertan
Gumbo, Tawanda
Antibacterial and Sterilizing Effect of Benzylpenicillin in Tuberculosis
title Antibacterial and Sterilizing Effect of Benzylpenicillin in Tuberculosis
title_full Antibacterial and Sterilizing Effect of Benzylpenicillin in Tuberculosis
title_fullStr Antibacterial and Sterilizing Effect of Benzylpenicillin in Tuberculosis
title_full_unstemmed Antibacterial and Sterilizing Effect of Benzylpenicillin in Tuberculosis
title_short Antibacterial and Sterilizing Effect of Benzylpenicillin in Tuberculosis
title_sort antibacterial and sterilizing effect of benzylpenicillin in tuberculosis
topic Experimental Therapeutics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786797/
https://www.ncbi.nlm.nih.gov/pubmed/29180526
http://dx.doi.org/10.1128/AAC.02232-17
work_keys_str_mv AT deshpandedevyani antibacterialandsterilizingeffectofbenzylpenicillinintuberculosis
AT srivastavashashikant antibacterialandsterilizingeffectofbenzylpenicillinintuberculosis
AT bendetpaula antibacterialandsterilizingeffectofbenzylpenicillinintuberculosis
AT martinkatheriner antibacterialandsterilizingeffectofbenzylpenicillinintuberculosis
AT cirrincionekaylen antibacterialandsterilizingeffectofbenzylpenicillinintuberculosis
AT leepoois antibacterialandsterilizingeffectofbenzylpenicillinintuberculosis
AT pasipanodyajotamg antibacterialandsterilizingeffectofbenzylpenicillinintuberculosis
AT dhedakeertan antibacterialandsterilizingeffectofbenzylpenicillinintuberculosis
AT gumbotawanda antibacterialandsterilizingeffectofbenzylpenicillinintuberculosis